First report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia

is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two...

Full description

Saved in:
Bibliographic Details
Published inEmerging microbes & infections Vol. 13; no. 1; p. 2300525
Main Authors Peng, Yaqin, Liu, Yue, Yu, Xuegao, Fang, Jingchun, Guo, Zhaowang, Liao, Kang, Chen, Peisong, Guo, Penghao
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis Ltd 01.12.2024
Taylor & Francis
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the gene. The isolates with Clade I presented Y132F mutation in the gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of candidemia and colonization after the first positive bloodstream. colonization was still observed after the first candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of in Guangdong, highlighting great challenges in clinical prevention and control.
AbstractList Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.
is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the gene. The isolates with Clade I presented Y132F mutation in the gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of candidemia and colonization after the first positive bloodstream. colonization was still observed after the first candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of in Guangdong, highlighting great challenges in clinical prevention and control.
Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.
Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of C. auris candidemia from two hospitals in Guangdong. The clinical and microbiological characteristics of these cases were investigated carefully. Two geographic clades, i.e. III and I, were found popular in different hospitals by whole genome sequencing analyses. All C. auris isolates from bloodstream were resistant to fluconazole, 5 of which belonged to Clade III harbouring VF125AL mutation in the ERG11 gene. The isolates with Clade I presented Y132F mutation in the ERG11 gene as well as resistance to amphotericin B. All isolates exhibited strong biofilm-forming capacity and non-aggregative phenotype. The mean time from admission to onset of C. auris candidemia was 39.4 days (range: 12 - 80 days). Despite performing appropriate therapeutic regimen, 42.9% (3/7) of patients experienced occurrences of C. auris candidemia and colonization after the first positive bloodstream. C. auris colonization was still observed after the first C. auris candidemia for 81 days in some patient. Microbiologic eradication from bloodstream was achieved in 85.7% (6/7) of patients at discharge. In conclusion, this study offers a crucial insight into unravelling the multiple origins of C. auris in Guangdong, highlighting great challenges in clinical prevention and control.
Author Chen, Peisong
Guo, Penghao
Liu, Yue
Yu, Xuegao
Fang, Jingchun
Guo, Zhaowang
Liao, Kang
Peng, Yaqin
Author_xml – sequence: 1
  givenname: Yaqin
  surname: Peng
  fullname: Peng, Yaqin
  organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
– sequence: 2
  givenname: Yue
  surname: Liu
  fullname: Liu, Yue
  organization: Department of Clinical Laboratory, The First Affiliated Hospital, Guangzhou University of Chinese Medicine, Guangzhou, People’s Republic of China
– sequence: 3
  givenname: Xuegao
  surname: Yu
  fullname: Yu, Xuegao
  organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
– sequence: 4
  givenname: Jingchun
  surname: Fang
  fullname: Fang, Jingchun
  organization: Department of Clinical Microbiology Laboratory, Nansha Division of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
– sequence: 5
  givenname: Zhaowang
  surname: Guo
  fullname: Guo, Zhaowang
  organization: Department of Clinical Laboratory, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, People’s Republic of China
– sequence: 6
  givenname: Kang
  surname: Liao
  fullname: Liao, Kang
  organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
– sequence: 7
  givenname: Peisong
  surname: Chen
  fullname: Chen, Peisong
  organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
– sequence: 8
  givenname: Penghao
  surname: Guo
  fullname: Guo, Penghao
  organization: Department of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, People’s Republic of China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38164742$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQjVARLaU_AWSJCwd2GdtJ7MABVStaKlXiAmfL8UfWq8Re7AQJ8efrZLdV2wvjg8czb57Hnve6OPHBm6J4i2GNgcMnkg2zCq8JELomFKAi1YvibI6v5sTJI_-0uEhpB9kY1CUuXxWnlOO6ZCU5K_5duZhGFM0-xBEFizbSa6clklN0CTmPrifpOx189xFtts7Lz0j1zjsle5ShaHAqhtaFPnRLTG1llGo0uXp0Ks2UDJm9S0Gb5aSWC8zg5JvipZV9MhfH_bz4dfXt5-b76vbH9c3m8nalKqjHFbEMgzW0rW1pGsiO5lrRlhqqVEN5S0C3lHHKQHFODFBMjeWaScCkrVp6XtwceHWQO7GPbpDxrwjSiSUQYidkzM32RtimKZmteIV5U3JGZQkUDG40B2V1XWWurweu_dQORivjxyj7J6RPM95tRRf-CAyM0bqmmeHDkSGG35NJoxhcUqbvpTdhSoI0MC_SlBn6_hl0F6bo818JikuCMaEL4bvHLT30cj_kDKgOgDyplKKxDxAMYtaTuNeTmPUkjnrKdV-e1Sk3ytGF-WWu_0_1HXB1zjo
CitedBy_id crossref_primary_10_1007_s15010_024_02378_8
crossref_primary_10_3390_diagnostics14192125
crossref_primary_10_1111_myc_70043
crossref_primary_10_1002_smll_202400741
Cites_doi 10.1080/21505594.2022.2054120
10.1080/21501203.2021.1994479
10.1016/j.cmi.2020.02.001
10.3389/fmicb.2020.01535
10.1007/s40121-022-00625-9
10.1128/JCM.00319-11
10.1111/myc.13471
10.1016/j.bioflm.2023.100126
10.1016/j.riam.2016.11.002
10.3201/eid2509.190040
10.1111/imj.14612
10.3390/biomedicines11041063
10.1111/myc.12790
10.1007/s10096-013-2027-1
10.1111/myc.12947
10.1186/s12879-023-08477-5
10.1080/22221751.2022.2100280
10.1016/j.jinf.2018.09.002
10.1016/S1473-3099(18)30597-8
10.1093/cid/ciac735
10.3201/eid2411.180368
10.1080/22221751.2021.1934557
10.1093/cid/ciw691
10.1111/myc.13626
10.1016/j.jcrc.2020.01.004
10.1128/JCM.02055-18
10.1016/j.ijid.2018.02.005
10.1111/myc.13396
10.1093/jac/dkx480
10.1007/978-1-4939-3052-4_14
10.1111/apm.13336
10.1016/j.eimc.2021.04.003
10.1038/s41426-018-0095-0
10.3390/microorganisms9040807
10.1093/mmy/myy054
10.3947/ic.2022.0008
10.1080/14787210.2023.2179036
10.1186/s12879-020-05543-0
10.1016/j.jiac.2023.03.018
10.1080/22221751.2022.2125349
10.1093/jac/dkx034
10.1016/j.jinf.2016.07.008
10.1016/j.ijid.2019.06.001
10.2147/IDR.S409708
10.3201/eid2509.190686
10.3201/eid2302.161320
10.1016/j.nmni.2016.07.003
10.1128/mSphere.00189-16
ContentType Journal Article
Copyright 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2024 The Author(s)
Copyright_xml – notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd 2024 The Author(s)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.1080/22221751.2023.2300525
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
Coronavirus Research Database
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Geography
DocumentTitleAlternate EMERGING MICROBES & INFECTIONS
EISSN 2222-1751
ExternalDocumentID oai_doaj_org_article_f9947f5851894873a4030e19d80cfd65
PMC10773663
38164742
10_1080_22221751_2023_2300525
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID 0YH
53G
5VS
7X7
88E
8FI
8FJ
AAHBH
AAYXX
ABUWG
ACGFS
ADBBV
ADRAZ
AENEX
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BENPR
BPHCQ
BVXVI
C6C
CCPQU
CITATION
DIK
EBS
ECGQY
EMOBN
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M1P
M48
M4Z
M~E
NAO
OK1
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
TDBHL
UKHRP
BCNDV
CGR
CUY
CVF
ECM
EIF
EJD
NPM
PJZUB
PPXIY
3V.
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c506t-2f710fe3b6f4e90e3bd8dc3b3e3cc938b20db378370c882e0313ef8d7a012b5b3
IEDL.DBID 7X7
ISSN 2222-1751
IngestDate Wed Aug 27 01:14:49 EDT 2025
Thu Aug 21 18:42:08 EDT 2025
Fri Jul 11 12:24:42 EDT 2025
Fri Jul 25 09:13:47 EDT 2025
Mon Jul 21 05:56:13 EDT 2025
Tue Jul 01 03:24:00 EDT 2025
Thu Apr 24 23:13:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Candida auris
candidemia
whole-genome sequencing
outcome
resistance
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c506t-2f710fe3b6f4e90e3bd8dc3b3e3cc938b20db378370c882e0313ef8d7a012b5b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
Supplemental data for this article can be accessed https://doi.org/10.1080/22221751.2023.2300525.
OpenAccessLink https://www.proquest.com/docview/3142112363?pq-origsite=%requestingapplication%
PMID 38164742
PQID 3142112363
PQPubID 2041957
ParticipantIDs doaj_primary_oai_doaj_org_article_f9947f5851894873a4030e19d80cfd65
pubmedcentral_primary_oai_pubmedcentral_nih_gov_10773663
proquest_miscellaneous_2909090294
proquest_journals_3142112363
pubmed_primary_38164742
crossref_primary_10_1080_22221751_2023_2300525
crossref_citationtrail_10_1080_22221751_2023_2300525
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-Dec
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: 2024-Dec
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: London
PublicationTitle Emerging microbes & infections
PublicationTitleAlternate Emerg Microbes Infect
PublicationYear 2024
Publisher Taylor & Francis Ltd
Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis Ltd
– name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_3_52_1
e_1_3_3_50_1
e_1_3_3_18_1
e_1_3_3_39_1
Salah H (e_1_3_3_17_1) 2021; 7
e_1_3_3_14_1
e_1_3_3_37_1
e_1_3_3_16_1
e_1_3_3_35_1
e_1_3_3_10_1
e_1_3_3_33_1
e_1_3_3_56_1
Gomez-Gaviria M (e_1_3_3_49_1) 2022; 9
e_1_3_3_12_1
e_1_3_3_31_1
e_1_3_3_54_1
e_1_3_3_40_1
AlJindan R (e_1_3_3_19_1) 2020; 7
e_1_3_3_7_1
e_1_3_3_9_1
e_1_3_3_29_1
e_1_3_3_25_1
e_1_3_3_48_1
e_1_3_3_27_1
e_1_3_3_46_1
e_1_3_3_3_1
e_1_3_3_21_1
e_1_3_3_44_1
e_1_3_3_5_1
e_1_3_3_23_1
e_1_3_3_30_1
e_1_3_3_51_1
Oladele R (e_1_3_3_42_1) 2022; 8
e_1_3_3_13_1
e_1_3_3_38_1
Ortiz-Roa C (e_1_3_3_34_1) 2023; 9
e_1_3_3_15_1
e_1_3_3_36_1
e_1_3_3_55_1
e_1_3_3_11_1
e_1_3_3_32_1
e_1_3_3_53_1
e_1_3_3_41_1
e_1_3_3_6_1
e_1_3_3_8_1
e_1_3_3_28_1
e_1_3_3_24_1
e_1_3_3_26_1
e_1_3_3_47_1
e_1_3_3_2_1
e_1_3_3_20_1
e_1_3_3_45_1
e_1_3_3_4_1
e_1_3_3_22_1
e_1_3_3_43_1
References_xml – ident: e_1_3_3_13_1
  doi: 10.1080/21505594.2022.2054120
– ident: e_1_3_3_38_1
  doi: 10.1080/21501203.2021.1994479
– ident: e_1_3_3_2_1
– ident: e_1_3_3_35_1
  doi: 10.1016/j.cmi.2020.02.001
– ident: e_1_3_3_48_1
  doi: 10.3389/fmicb.2020.01535
– ident: e_1_3_3_36_1
  doi: 10.1007/s40121-022-00625-9
– volume: 8
  issue: 8
  year: 2022
  ident: e_1_3_3_42_1
  article-title: Emergence and genomic characterization of multidrug resistant candida auris in Nigeria, West Africa
  publication-title: J Fungi (Basel)
– ident: e_1_3_3_44_1
  doi: 10.1128/JCM.00319-11
– ident: e_1_3_3_47_1
  doi: 10.1111/myc.13471
– ident: e_1_3_3_55_1
  doi: 10.1016/j.bioflm.2023.100126
– ident: e_1_3_3_27_1
  doi: 10.1016/j.riam.2016.11.002
– ident: e_1_3_3_4_1
  doi: 10.3201/eid2509.190040
– ident: e_1_3_3_6_1
  doi: 10.1111/imj.14612
– ident: e_1_3_3_50_1
  doi: 10.3390/biomedicines11041063
– ident: e_1_3_3_7_1
  doi: 10.1111/myc.12790
– ident: e_1_3_3_32_1
  doi: 10.1007/s10096-013-2027-1
– ident: e_1_3_3_56_1
  doi: 10.1111/myc.12947
– ident: e_1_3_3_29_1
  doi: 10.1186/s12879-023-08477-5
– ident: e_1_3_3_41_1
  doi: 10.1080/22221751.2022.2100280
– ident: e_1_3_3_40_1
  doi: 10.1016/j.jinf.2018.09.002
– ident: e_1_3_3_26_1
  doi: 10.1016/S1473-3099(18)30597-8
– ident: e_1_3_3_30_1
  doi: 10.1093/cid/ciac735
– ident: e_1_3_3_24_1
  doi: 10.3201/eid2411.180368
– ident: e_1_3_3_53_1
  doi: 10.1080/22221751.2021.1934557
– ident: e_1_3_3_11_1
  doi: 10.1093/cid/ciw691
– ident: e_1_3_3_33_1
  doi: 10.1111/myc.13626
– ident: e_1_3_3_8_1
  doi: 10.1016/j.jcrc.2020.01.004
– ident: e_1_3_3_22_1
  doi: 10.1128/JCM.02055-18
– ident: e_1_3_3_43_1
  doi: 10.1016/j.ijid.2018.02.005
– ident: e_1_3_3_3_1
  doi: 10.1111/myc.13396
– volume: 7
  issue: 1
  year: 2020
  ident: e_1_3_3_19_1
  article-title: Drug resistance-associated mutations in ERG11 of multidrug-resistant candida auris in a tertiary care hospital of eastern Saudi arabia
  publication-title: J Fungi (Basel)
– ident: e_1_3_3_14_1
  doi: 10.1093/jac/dkx480
– volume: 7
  issue: 3
  year: 2021
  ident: e_1_3_3_17_1
  article-title: Genomic epidemiology of candida auris in Qatar reveals hospital transmission dynamics and a South Asian origin
  publication-title: J Fungi (Basel)
– ident: e_1_3_3_20_1
  doi: 10.1007/978-1-4939-3052-4_14
– ident: e_1_3_3_51_1
  doi: 10.1111/apm.13336
– ident: e_1_3_3_45_1
  doi: 10.1016/j.eimc.2021.04.003
– ident: e_1_3_3_16_1
  doi: 10.1038/s41426-018-0095-0
– volume: 9
  issue: 1
  year: 2022
  ident: e_1_3_3_49_1
  article-title: Non-albicans candida species: immune response, evasion mechanisms, and New plant-derived alternative therapies
  publication-title: J Fungi (Basel)
– volume: 9
  issue: 7
  year: 2023
  ident: e_1_3_3_34_1
  article-title: Mortality caused by candida auris bloodstream infections in comparison with other candida species, a multicentre retrospective cohort
  publication-title: J Fungi (Basel)
– ident: e_1_3_3_12_1
  doi: 10.3390/microorganisms9040807
– ident: e_1_3_3_52_1
  doi: 10.1093/mmy/myy054
– ident: e_1_3_3_9_1
  doi: 10.3947/ic.2022.0008
– ident: e_1_3_3_18_1
– ident: e_1_3_3_54_1
  doi: 10.1080/14787210.2023.2179036
– ident: e_1_3_3_5_1
  doi: 10.1186/s12879-020-05543-0
– ident: e_1_3_3_46_1
  doi: 10.1016/j.jiac.2023.03.018
– ident: e_1_3_3_15_1
  doi: 10.1080/22221751.2022.2125349
– ident: e_1_3_3_37_1
  doi: 10.1093/jac/dkx034
– ident: e_1_3_3_31_1
  doi: 10.1016/j.jinf.2016.07.008
– ident: e_1_3_3_28_1
  doi: 10.1016/j.ijid.2019.06.001
– ident: e_1_3_3_25_1
  doi: 10.2147/IDR.S409708
– ident: e_1_3_3_10_1
  doi: 10.3201/eid2509.190686
– ident: e_1_3_3_21_1
  doi: 10.3201/eid2302.161320
– ident: e_1_3_3_39_1
  doi: 10.1016/j.nmni.2016.07.003
– ident: e_1_3_3_23_1
  doi: 10.1128/mSphere.00189-16
SSID ssj0000706414
Score 2.3624108
Snippet is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we reported 7 cases of...
Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we...
Candida auris is an emerging multidrug-resistant fungal pathogen worldwide. To date, it has not been reported in Guangdong, China. For the first time, we...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 2300525
SubjectTerms Antifungal agents
Antifungal Agents - pharmacology
Antifungal Agents - therapeutic use
Biofilms
Bioinformatics
Candida
Candida auris
candidemia
Candidemia - drug therapy
Candidemia - epidemiology
Candidemia - microbiology
China - epidemiology
Drug Resistance and Novel Antimicrobial Agents
Drug Resistance, Fungal - genetics
Genetic testing
Genomes
Geography
Humans
Infections
Medical laboratories
Microbial Sensitivity Tests
Mutation
outcome
Pathogens
Patients
Phylogenetics
resistance
Whole genome sequencing
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYhp0IJbdqmbpOgQo51YkvyQ721oUsoNKcEchN6pobGDt3NqX--M5Jt1iGQS_HFlh-SNSPPNx7pG0JOtLXcMOtyDcYqFwKHVGtZLr3j3opQcIMR3Z-X9cW1-HFT3Wyl-sI5YYkeOHXcWZBSNAGDV60EcM21ALX0pXRtYYOrI3sp2LwtZyp-gxswtaWYluy0xRnYQUDfFbqEjOP0Z0zgtjBGkbP_KaD5eL7klgFavSJ7I3KkX1OLX5Md3--Tl-m3G02rid6Qv6sO4BxNkQA6BHqOy1acpsgetKZdT0En-ls39Lefacyd_YVOiyMpXErvupmZKZbZJaEzPrKh_r5bD87HIxsr8HedfkuuV9-vzi_yMb9Cbqui3uQsALwInps6CC8L2HGtA9Fxz62VvDWscIY3SI9jAYh7pHn0oXWNBqtmKsPfkd1-6P17QuFDIQCb2NKU8KxamwqqKKUInJeVlnVGxNTRyo7k45gD47cqR47SST4K5aNG-WTkdL7tPrFvPHfDN5TifDGSZ8cCUCk1qpR6TqUycjjpgBpH9FrxUoCvzHjNM_JpPg1jEQMsuvfDw1oxWeDGpMjIQVKZuSUYoIUuYhlpF8q0aOryTN_9inzf4KE3HJDhh__xch_JC-gwkWbkHJLdzZ8HfwS4amOO4xD6B_ttGuQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9RAEB9qfVAQ0ao1WmUFH01NspuPFUS0eBShPnnQtyX7dQ20Sb27gsV_3plkE4xU5V7ukuxm2ZnZ-c3N7m8AXtfGcJ0ZG9forGIhyKQqk8XSWe6M8AnXlNE9-VocL8WX0_x0B0ZChTCBmxtDO6ontVyfH_74fv0BDf592CH3Fl0cAuucor2M085mqs12C26jcyrJVk8C4u8X5xJ9cCrGszx_az3zUj2Z_00I9M-NlL95psUDuB8gJfs46MBD2HHtHtwJ1c3Prvfg3vDfHBuOHD2Cn4sGMR8b0gWs8-yIzrbYmhHF0IY1LUPFaVe2a1dvWF9g-x0bT1AyfJRdNBN9U3_NzFmfqcuSuctm01nX_zL9C9xFUz-G5eLzt6PjOBRhiE2eFNs484hBvOO68MLJBL_YyqJ8uePGSF7pLLGal8ShYxCtO-KCdL6yZY2uT-eaP4HdtmvdU2C4mggEMCbVKfZV1DrHV6RSeM7TvJZFBGKcdGUCQzkVyjhXaSAyHWWlSFYqyCqCw6nZ5UDR8b8Gn0ii08PEsN1f6NYrFQxWeSlF6SlpWkkM6ngtcDl0qbRVYrwtsJODUR_UqLWKpwID6owXPIJX0200WMrC1K3rrjYqkwl9Miki2B_UZxoJZXFxirIIqplizYY6v9M2Zz0pOIbxJUf4-Ozf43oOd3EqxLAh5wB2t-sr9wJh1Va_7A3lF75XGr8
  priority: 102
  providerName: Scholars Portal
Title First report of Candida auris in Guangdong, China: clinical and microbiological characteristics of 7 episodes of candidemia
URI https://www.ncbi.nlm.nih.gov/pubmed/38164742
https://www.proquest.com/docview/3142112363
https://www.proquest.com/docview/2909090294
https://pubmed.ncbi.nlm.nih.gov/PMC10773663
https://doaj.org/article/f9947f5851894873a4030e19d80cfd65
Volume 13
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3da9RAEB9s-6AgovUrWo8VfDQ2yW4-1hexpcchtIhYOJ9Csh_XgE2uzfWh-M87s9lET0QJHLl8bJadmZ3ZmdnfALyplOJ1onRYobIKhSCRKlQSSqO5UcJGvKaI7ulZtjgXn5bp0jvcep9WOc6JbqLWnSIf-SGPBa5VEp7xD-urkKpGUXTVl9DYgT2CLqOUrnyZTz4WZOdMxGLcuFNEh6gN0QZPaWGYcEqCpjJuWyrJIff_zdz8M2vyNzU0fwgPvP3IPg4EfwR3TLsPd30p84vbfbg_OOLYsL_oMfyYN2jgsSE2wDrLjmkji64Y4Qn1rGkZckm70l27estcNe33bNwuyfBRdtlMWE3umtqGeKYmc2bWTd9p4_4p9wFz2VRP4Hx-8vV4EfqKC6FKo2wTJhYNDmt4nVlhZIQnutBITG64UpIXdRLpmucEmKPQNDcE_GhsofMK9Vyd1vwp7LZda54Dw6lDoLWi4jrGtrKqTvETsRSW8zitZBaAGAe9VB6OnKpifC9jj1o60qokWpWeVgG8m15bD3gc_3vhiCg6PUxw2u5Cd70qvXSWVkqRW4qQFhJXcLwSOPeZWOoiUlZn2MjByA-ll_G-_MWRAbyebqN0Usilak1305eJjOhIpAjg2cA-U08oZItDlARQbDHWVle377TNhUMAxzV7ztFWfPHvfr2EezgUYsi-OYDdzfWNeYU21KaewU70bTFz4jKDvaOTs89fZs4fgb-novgJ4hAblA
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD7U7UMFEa231Koj6JuxyczkMoKIrV22tl1EWuhbTGYm20CbrM0WKf4nf6Pn5KYrok8lL7lOhjn3OTPfAXiRai0yro2borFypSSRijV3lTXCapl7IqOM7uE0nBzLjyfByQr86PfC0LLKXic2itpUmubIt4QvMVbhIhTv5l9dqhpF2dW-hEbLFvv26huGbPXbvQ9I35ecj3ePdiZuV1XA1YEXLlyeo1HNrcjCXFrl4YmJDXZYWKG1EnHGPZOJiEBhNLqflsANbR6bKEVdngWZwHZvwKoUGMqMYHV7d_rp8zCrgwIUSl_2W4VibwvtL3r9AYWiXNCyayoct2QEm1oBf3Nw_1yn-ZvhG9-B253Hyt63LHYXVmy5Dmtd8fTTq3W41U79sXZH0z34Pi7QpWRtNoJVOduhrTMmZYRgVLOiZMiX5cxU5ewVa-p3v2H9Bk2Gr7LzYkCHau7pZVBpajJidl7UlbHNlW5-YM-L9D4cXws1HsCorEr7CBgqK4n-kfYzH9sK0yzAX_hK5kL4QapCB2Q_6InuANCpDsdZ4nc4qT2tEqJV0tHKgdfDZ_MWAeR_H2wTRYeXCcC7uVFdzJJOHyS5UjLKKScbK4wZRSpR21pfmdjTuQmxkc2eH5JOq9TJLxlw4PnwGPUBJXnS0laXdcKVRwdX0oGHLfsMPaEkMQ4RdyBeYqylri4_KYvTBnPc96JIoHe68e9-PYO1ydHhQXKwN91_DDdxWGS79mcTRouLS_sEPbhF9rQTGwZfrltSfwIe4VXg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=First+report+of+Candida+auris+in+Guangdong%2C+China%3A+clinical+and+microbiological+characteristics+of+7+episodes+of+candidemia&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Peng%2C+Yaqin&rft.au=Liu%2C+Yue&rft.au=Yu%2C+Xuegao&rft.au=Fang%2C+Jingchun&rft.date=2024-12-01&rft.pub=Taylor+%26+Francis+Ltd&rft.eissn=2222-1751&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1080%2F22221751.2023.2300525
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon